Overview

A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2029-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness and safety of ozanimod in Chinese adults with relapsing multiple sclerosis.
Phase:
PHASE4
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
ozanimod